New nanoscale devices, made of synthetic proteins, have been designed to target a therapeutic agent only to cells with a specific, predetermined combinations of cell surface markers. They operate on their own and search out cells they were programmed to find. The hope is that they might guide CAR T cancer therapy, and other treatments where precision is critical, through a sort of molecular beacon.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023